The most recent Success stories from EU Research. Select a theme or country from the menus on the left to see more articles
Health & life sciences - Drugs & drug processes
Tick (check) box to add article to PDF "basket"
Type 1 diabetes develops in childhood, requiring constant - often painful - management from the start. EU-funded researchers are testing an artificial pancreas that could transform the quality of life of youngsters suffering from the disease.
Published: 14 November 2018
Most vaccines need to be kept cool during transport and storage, but this can be hard to accomplish. EU-funded researchers keen to tackle this healthcare challenge have developed heat-tolerant and even needle-free formulations of an HIV-1 vaccine candidate. They expect their processes to work for many other vaccines as well.
Published: 30 October 2018
Monoclonal antibodies have emerged as a powerful weapon in the fight against a variety of diseases, including several types of cancer - but producing them remains a costly process. Crystallisation is the way forward, say EU-funded researchers working on an innovation that could make it easier, greener and far more affordable.
Published: 6 July 2018
An EU-funded project aims to identify and maximise the potential of novel vaccines to end the global tuberculosis epidemic. These could save lives, stem the spread of infection and shorten treatment for the often deadly, airborne disease.
Published: 21 June 2018
For patients with rare genetic mutations of the debilitating disease cystic fibrosis, there are few options for effective treatment. EU-funded researchers are working to meet their needs, using new developments in personalised medicine to advance the testing of novel and promising drugs.
Published: 19 June 2018
Hundreds of millions of people each year are infected with Plasmodium vivax, the most widespread form of malaria worldwide. An EU-funded project is tackling the mosquito-borne parasite, leading cutting-edge research efforts to accelerate the development of effective vaccines.
Published: 25 April 2018
EU-funded researchers are using the latest vaccine technologies and antigen discovery tools to develop a multi-stage, multi-antigen vaccine against Plasmodium falciparum, the parasite responsible for the deadliest form of malaria.
Published: 25 April 2018
Using innovative nanotechnologies, an EU-funded project is developing more efficient and sustainable vaccine manufacturing processes. The cost of vaccines puts a brake on wider immunisation, so these new processes will find broad application - especially in developing economies.
Published: 19 February 2018
Rapid diagnosis is vital for controlling outbreaks of the deadly Ebola virus. Currently this can only be done in complex laboratories and samples from infected patients are dangerous to handle and transport. Faced with this challenge, an EU and industry-funded project is developing fast, local tests to spot infection quickly and safely, helping to contain its spread and saving lives in the process.
Published: 1 December 2017
The EU-funded SWEETOOLS project aims to improve our understanding of the role of sugars in human biology. Exploring optimised versions of biosynthesised proteins combined with chemically synthesised drugs could help the development of novel biomedicines and vaccines targeting, for example, influenza.
Published: 22 November 2017